← 홈

건선 · TNF-α

18개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 18개
AntibodySHOTFDACuratedFDABiologicAbbVieApproved

adalimumab (Humira, Hyrimoz, Amjevita)

Rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, axial SpA · TNF-α

#TNF-#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 98.85%임상시험 420상태 APPROVED
AntibodySHOTFDACuratedFDABiologicAmgenApproved

etanercept (Enbrel, Erelzi)

RA, psoriasis, psoriatic arthritis, ankylosing spondylitis · TNF

#TNF#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 73.4%임상시험 117상태 APPROVED
AntibodyAbbVieApproved

adalimumab (Humira, Adalimumab treatment arm)

Psoriasis; Cardiovascular Diseases · Psoriasis

#Psoriasis#Antibody#Approved#인기#항체+5
효능 ORR 2%임상시험 56상태 ACTIVE
AntibodystaleAbbVieApproved

adalimumab (Humira, Humira (adalimumab))

Psoriasis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Approved#항체#면역항체+3
효능 ORR 98.4%임상시험 6상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Adalimumab Every Week)

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Adalimumab every other week)

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Adalimumab originator)

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbVieApproved

adalimumab (Humira, Adalimumab, etanercept, infliximab)

Moderate to Severe Psoriasis.; Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytok… · Moderate to Severe Psoriasis.

#ModeratetoSeverePsoriasis#Antibody#Approved#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleUniversity Hospital, GhentApproved

adalimumab (Humira, Dose tapering of adalimumab in patients with supratheurapeutic serum trough levels)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

adalimumab (Humira, Dovobet, neotigason, etanercept, adalimumab. infliximab)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSandozPhase 3

adalimumab (Humira, GP2017 Adalimumab)

Plaque Type Psoriasis · Plaque Type Psoriasis

#PlaqueTypePsoriasis#Antibody#Phase3#항체#면역항체+2
효능 ORR 46.5%임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

Psoriatic Arthritis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

IFX + MTX (Infliximab + methotrexate, Infliximab + methotrexate (IFX + MTX))

Arthritis, Psoriatic · Arthritis, Psoriatic

#ArthritisPsoriatic#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab and methotrexate (Infliximab and methotrexate)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleSamsung Bioepis Co., Ltd.Approved

Adalimumab Biosimilar (SB5, SB5 (Adalimumab Biosimilar))

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Approved#항체#면역항체+2
효능 ORR 64%임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

adalimumab (Humira, adalimumab and methotrexate)

Psoriasi · Psoriasi

#Psoriasi#Antibody#Preclinical#항체#면역항체+2
효능 ORR 6.35%임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

adalimumab (Humira, adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate)

Immunoclassification; Psoriasis · Immunoclassification

#Immunoclassification#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleUniversity Hospital, Gentofte, …Preclinical

adalimumab (Humira, subjects will receive either infliximab, adalimumab or etanercept)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE